Background: Automated cardiac image interpretation has the potential to transform clinical
practice in multiple ways, including enabling serial assessment of cardiac function by …

Aims To date, clinical evidence of microvascular dysfunction in patients with heart failure (HF)
with preserved ejection fraction (HFpEF) has been limited. We aimed to investigate the …

Objectives : This study sought to investigate how right ventricular (RV) contractile function
and its coupling with pulmonary circulation (PC) stratify clinical phenotypes and outcome in …

Background: A systemic proinflammatory state has been hypothesized to mediate the
association between comorbidities and abnormal cardiac structure/function in heart failure with …

Aims Diagnosing heart failure with preserved ejection fraction (HFpEF) is challenging. The
newly proposed HFA‐PEFF algorithm entails a stepwise approach. Step 1, typically …

Patients with rare conditions such as cardiac amyloidosis (CA) are difficult to identify, given
the similarity of disease manifestations to more prevalent disorders. The deployment of …

We sought to evaluate whether unbiased machine learning of dense phenotypic data (“phenomapping”)
could identify distinct hypertension subgroups that are associated with the …

Aim Epicardial adipose tissue (EAT) may play a role in the pathophysiology of heart failure
with preserved ejection fraction (HFpEF). We investigated associations of EAT with proteomics…

Ranolazine, a late inward sodium current and fatty acid oxidation inhibitor, may improve right
ventricular (RV) function in pulmonary arterial hypertension (PAH); however, the safety and …

Impaired left atrial (LA) function in heart failure with preserved ejection fraction (HFpEF) is
associated with adverse outcomes. A subgroup of HFpEF may have LA myopathy out of …